NO922512L - Tetrahydropyrrolo(1,2-a)pyrazin-4-spiro-3'-pyrrolidinderivater, fremgangsmaate for fremstilling derav, samt farmasoeytiske preparater inneholdende slike - Google Patents

Tetrahydropyrrolo(1,2-a)pyrazin-4-spiro-3'-pyrrolidinderivater, fremgangsmaate for fremstilling derav, samt farmasoeytiske preparater inneholdende slike

Info

Publication number
NO922512L
NO922512L NO92922512A NO922512A NO922512L NO 922512 L NO922512 L NO 922512L NO 92922512 A NO92922512 A NO 92922512A NO 922512 A NO922512 A NO 922512A NO 922512 L NO922512 L NO 922512L
Authority
NO
Norway
Prior art keywords
tetrahydropyrrolo
pyrazine
spiro
derivatives
pyrrolidein
Prior art date
Application number
NO92922512A
Other languages
English (en)
Other versions
NO300637B1 (no
NO922512D0 (no
Inventor
Toshiyuki Negoro
Makoto Murata
Shozo Ueda
Buichi Fujitani
Yoshiyuki Ono
Original Assignee
Dainippon Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co filed Critical Dainippon Pharmaceutical Co
Publication of NO922512D0 publication Critical patent/NO922512D0/no
Publication of NO922512L publication Critical patent/NO922512L/no
Publication of NO300637B1 publication Critical patent/NO300637B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/20Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
NO922512A 1991-06-26 1992-06-25 Tetrahydropyrrolo£1,2-a|pyrazin-4-spiro-3'-pyrrolidinderivater samt farmasöytiske preparater inneholdende slike NO300637B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP03183185 1991-06-26

Publications (3)

Publication Number Publication Date
NO922512D0 NO922512D0 (no) 1992-06-25
NO922512L true NO922512L (no) 1992-12-28
NO300637B1 NO300637B1 (no) 1997-06-30

Family

ID=16131263

Family Applications (1)

Application Number Title Priority Date Filing Date
NO922512A NO300637B1 (no) 1991-06-26 1992-06-25 Tetrahydropyrrolo£1,2-a|pyrazin-4-spiro-3'-pyrrolidinderivater samt farmasöytiske preparater inneholdende slike

Country Status (21)

Country Link
US (1) US5258382A (no)
EP (1) EP0520320B1 (no)
JP (1) JP2516147B2 (no)
KR (1) KR100241196B1 (no)
CN (1) CN1034176C (no)
AT (1) ATE157980T1 (no)
AU (1) AU648901B2 (no)
CA (1) CA2071273C (no)
DE (1) DE69222096T2 (no)
DK (1) DK0520320T3 (no)
ES (1) ES2108717T3 (no)
FI (1) FI98066C (no)
GR (1) GR3024870T3 (no)
HK (1) HK1001728A1 (no)
HU (1) HU218214B (no)
IE (1) IE921891A1 (no)
MX (1) MX9203231A (no)
NO (1) NO300637B1 (no)
NZ (1) NZ243255A (no)
TW (1) TW202450B (no)
ZA (1) ZA924425B (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3195455B2 (ja) * 1993-01-06 2001-08-06 ウェルファイド株式会社 キノリン−3−酢酸誘導体、その製造法と用途
JP3681082B2 (ja) * 1996-06-27 2005-08-10 住友ベークライト株式会社 イミド環含有エポキシ樹脂及びエポキシ樹脂組成物
JP2007246539A (ja) * 1997-10-20 2007-09-27 Dainippon Sumitomo Pharma Co Ltd 速溶性医薬組成物
AU740299B2 (en) 1997-10-20 2001-11-01 Dainippon Sumitomo Pharma Co., Ltd. Fast-dissolving pharmaceutical composition
DK1038525T3 (da) * 1997-10-20 2004-08-02 Dainippon Pharmaceutical Co Stabiliseret farmaceutisk præparat af tetrahydropyrrolo[1,2-a]pyrazin-4-spiro-3'-pyrrolidin
CA2390557A1 (en) * 1999-11-11 2001-05-17 Kyorin Pharmaceutical Co., Ltd. Solid preparations for oral use
MXPA02006134A (es) 1999-12-21 2002-12-13 Guilford Pharm Inc Compuestos derivados de hidantoina, composiciones farmaceuticas y metodos de uso de los mismos.
WO2004043491A1 (ja) * 2002-11-14 2004-05-27 Ono Pharmaceutical Co., Ltd. 脊柱管狭窄症治療剤
US8058456B2 (en) * 2006-07-07 2011-11-15 Dainippon Sumitomo Pharma Co., Ltd. Optically active 3-amino-2,5-dioxopyrrolidine-3-carboxylate, process for production of the compound, and use of the compound
EP2058300B1 (en) * 2006-08-31 2013-01-09 Dainippon Sumitomo Pharma Co., Ltd. Succinic acid diester derivative, process for production thereof, and use of the derivative in the production of pharmaceutical preparation
WO2008035735A1 (fr) 2006-09-20 2008-03-27 Nissan Chemical Industries, Ltd. Procédé de production d'un composé de succinimide optiquement actif
KR20090057388A (ko) * 2006-09-27 2009-06-05 닛산 가가쿠 고교 가부시키 가이샤 숙신이미드 화합물의 제조 방법
JP5113070B2 (ja) * 2006-09-29 2013-01-09 大日本住友製薬株式会社 2,5−ジオキソピロリジン−3−カルボキシレート類の製造方法
EP2095812A4 (en) 2006-10-25 2011-07-13 Dainippon Sumitomo Pharma Co NON-AGGLUTINANT GRANULAR PREPARATION
WO2008081860A1 (ja) * 2006-12-28 2008-07-10 Dainippon Sumitomo Pharma Co., Ltd. 光学活性コハク酸イミド誘導体およびその製造方法ならびにその使用
JPWO2008136527A1 (ja) * 2007-05-08 2010-07-29 大日本住友製薬株式会社 光学活性ジオキソピロリジン誘導体の精製方法
JP2010533127A (ja) * 2007-07-13 2010-10-21 コミッサリア ア レネルジー アトミーク エ オ ゼネルジ ザルタナテイヴ 神経因性疼痛のためのampa受容体アンタゴニストおよびアルドースレダクターゼ阻害剤
JP2011026201A (ja) * 2007-10-17 2011-02-10 Mitsubishi Tanabe Pharma Corp 光学活性ピロリル−コハク酸イミド誘導体の立体選択的な製造方法
WO2010090031A1 (ja) 2009-02-06 2010-08-12 大日本住友製薬株式会社 光学活性スクシンイミド誘導体の製造方法及びその中間体
WO2012014953A1 (ja) 2010-07-29 2012-02-02 大日本住友製薬株式会社 光学活性スクシンイミド誘導体の製造方法
WO2012105610A1 (ja) 2011-02-02 2012-08-09 公立大学法人名古屋市立大学 眼内血管新生及び/又は眼内血管透過性亢進を伴う疾患の予防又は治療のための医薬
JP6655018B2 (ja) * 2014-09-11 2020-02-26 大日本住友製薬株式会社 点眼用懸濁製剤
CN106928234A (zh) * 2017-02-07 2017-07-07 上海合全药业股份有限公司 (2‑苄基‑1,2,3,4‑四氢吡咯并[1,2‑a]吡嗪)‑4‑甲醇的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60142984A (ja) * 1983-12-28 1985-07-29 Kyorin Pharmaceut Co Ltd 新規なスピロピロリジン−2,5−ジオン誘導体およびその製造法
WO1986001107A1 (en) * 1984-08-14 1986-02-27 Pfizer Inc. Tetracyclic spiro-hydantoin aldose reductase inhibitors, compositions and methods of making
JPS63132889A (ja) * 1986-11-21 1988-06-04 Tanabe Seiyaku Co Ltd キナゾリノン誘導体
AU617541B2 (en) * 1988-10-20 1991-11-28 Wyeth Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors

Also Published As

Publication number Publication date
NZ243255A (en) 1994-03-25
HUT63424A (en) 1993-08-30
KR100241196B1 (ko) 2000-03-02
HU9202105D0 (en) 1992-10-28
ZA924425B (en) 1993-03-31
TW202450B (no) 1993-03-21
FI98066B (fi) 1996-12-31
EP0520320A2 (en) 1992-12-30
HU218214B (hu) 2000-06-28
DE69222096D1 (de) 1997-10-16
IE921891A1 (en) 1992-12-30
EP0520320A3 (en) 1993-03-24
CN1068825A (zh) 1993-02-10
CA2071273A1 (en) 1992-12-27
JP2516147B2 (ja) 1996-07-10
CA2071273C (en) 2002-08-20
FI922848A (fi) 1992-12-27
FI922848A0 (fi) 1992-06-18
MX9203231A (es) 1993-08-01
FI98066C (fi) 1997-04-10
EP0520320B1 (en) 1997-09-10
ES2108717T3 (es) 1998-01-01
NO300637B1 (no) 1997-06-30
DK0520320T3 (da) 1997-10-13
ATE157980T1 (de) 1997-09-15
KR930000519A (ko) 1993-01-15
NO922512D0 (no) 1992-06-25
AU1848392A (en) 1993-01-14
JPH05186472A (ja) 1993-07-27
AU648901B2 (en) 1994-05-05
CN1034176C (zh) 1997-03-05
HK1001728A1 (en) 1998-07-03
DE69222096T2 (de) 1998-01-22
GR3024870T3 (en) 1998-01-30
US5258382A (en) 1993-11-02

Similar Documents

Publication Publication Date Title
NO922512D0 (no) Tetrahydropyrrolo(1,2-a)pyrazin-4-spiro-3'-pyrrolidinderivater, fremgangsmaate for fremstilling derav, samt farmasoeytiske preparater inneholdende slike
AU572252B2 (en) 5-methyl-4,5 dihydro-3(2h) pyridazinone derivatives
NO912805L (no) Fremgangsmaate for fremstilling av pyrazolopyridin-forbindelser.
CA2029420A1 (en) Pharmaceutical compositions and methods for inhibition of maillard's reaction
TW377352B (en) Pyrido[2,3-d]pyrimidine derivatives and pharmaceutical compositions thereof
CA2042113A1 (en) Spiro-isoquinoline-pyrrolidines and analogs thereof useful as aldose reductase inhibitors
ATE152352T1 (de) Pharmazeutische zusammensetzungen zur hemmung der maillardreaktion
HU893127D0 (en) Process for the preparation of novel spiro-(imidazolidino-naphtaline) derivatives and pharmaceutical compositions containing such compounds as active ingredient
AU580677B2 (en) Bis (6-oxo-hydropyridazinyl)benzene derivatives
AU586089B2 (en) Phosphodiesterace type 111 inhibitors having a thiadiazinone ring as part of a tricyclic structure
DE69218626D1 (de) 1'-amino-2[(benzothiazolyl)methyl] spiro [isochinolin-4(1h), 3'-pyrrolidine]-1,2',3,5'-tetrone und analoge davon verwendbar als aldosereduktase luhibitoren

Legal Events

Date Code Title Description
MK1K Patent expired